GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology™, announced a strategic collaboration to industrialize DNA-based data storage, a technology poised to transform how the world preserves data in the age of …
GTCR, a leading private equity firm, announced that it has closed the previously announced acquisition of Zentiva, a leading European generics pharmaceutical company, from Advent, a leading global private equity investor. GTCR will partner with Zentiva's management team, led by Chief Executive Officer Steffen Saltoft…
ABK Biomedical, Inc. and COR Development are proud to announce a strategic partnership to develop a state-of-the-art GMP manufacturing facility in Cartwright Business Park, Ashland, Missouri. This strategic project will provide the long-term future commercial scale production of Eye90 microspheres®, a designated FDA b…
Cytiva, a Danaher company and a leader in the life sciences industry, announced that it has signed a FlexFactory™ contract with Yoshindo, supporting the company’s plans to establish domestic biosimilar drug substances manufacturing capabilities for the Japanese market. Yoshindo plans to begin supplying biosimilar pro…
ICON plc, a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new ‘research-ready,’ connected site network model for clinical tr…
Eli Lilly and Company and Centessa Pharmaceuticals plc, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today announced a definitive agreement for Lilly to acquire Centessa. "Centessa is at the forefront of orexin scienc…
Adragos Pharma, a global contract development and manufacturing organization (CDMO), announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. The Maisons-Alfort site is one of Europe’s largest manufacturing facilities for sterile injectables…
Global pharma major Lupin Limited announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO). The acquisition represents a significant milestone in Lupin's strategy to expand its specialty …
Novartis announced that it has entered into an agreement to acquire Excellergy, Inc., a private biotech company developing next-generation anti-IgE therapies for IgE-driven diseases. The proposed acquisition adds Exl-111, a half-life extended, high-affinity anti-IgE antibody in Phase 1. The acquisition builds on de…
The Global Health Innovative Technology (GHIT) Fund and Thailand Science Research and Innovation (TSRI) have signed a memorandum of understanding (MOU) to strengthen their partnership through co-funding opportunities for research and development (R&D) targeting malaria, tuberculosis, neglected tropical diseases (N…
Page 14 of 39